Dear Editor,

Ataxia with oculomotor apraxia type 1 (AOA1, MIM 208920) is an autosomal recessive disorder characterized by early-onset cerebellar ataxia, polyneuropathy, oculomotor apraxia, hypoalbuminemia, and hypercholesterolemia.[@B1] It is caused by pathogenic variants of *APTX*, which encodes the aprataxin protein that is involved in DNA strand-break repair.[@B1]

We recruited a consanguineous family (coded as RDHM-02) with individuals affected by an undiagnosed movement disorder ([Fig. 1A](#F1){ref-type="fig"}). The proband (VI:11, aged 40 years) was identified by personal contact. He had dysarthria and weakness of lower limb muscles. The disease onset reportedly occurred at ages of 2--6 years. The family history was obtained, and the affected individuals underwent standardized videotaping. The videos were evaluated by movement-disorders experts (C.K. and N.B.) after exome sequencing results were obtained. The proband and the other affected individuals in family RDHM-02 had cerebellar ataxia with severe gait impairment. Individual VI:11 exhibited severe polyneuropathy and a complete loss of ambulation by the age of 7 years, while individuals VI:13, VII:1, and VII:6 had ocular apraxia. Mild upper limb and moderate lower limb dystonia were observed in all affected family members except individual VI:11. Individual VII:6 exhibited a distinct high-frequency dystonic hand tremor and mild distal chorea of the upper limbs. The serum cholesterol level (234 mg/dL) was elevated in the oldest affected individual (who was aged 40 years), while the albumin levels were normal ([Supplementary Table 1](#S1){ref-type="supplementary-material"} in the online-only Data Supplement).

Genomic DNA was extracted from blood samples.[@B2] Whole-exome sequencing was performed for two individuals (VI:11 and VI:12), and the variants were prioritized.[@B3] Sanger sequencing confirmed the segregation of a novel homozygous nonsense mutation \[c.388C\>T (p.Gln130Ter)\] in *APTX* (NM_175073.2) associated with the phenotype ([Fig. 1A and B](#F1){ref-type="fig"}). The variant was absent from public databases and the DNA of 100 controls (200 chromosomes were analyzed).

*APTX* ([Fig. 1C](#F1){ref-type="fig"}) encodes aprataxin, which is composed of three main domains: FHA (an N-terminal forkhead-associated domain), HIT (a histidine triad domain), and Znf (a C-terminal Cys~2~His~2~ zinc finger domain) ([Fig. 1D](#F1){ref-type="fig"}). Relatively few variants of *APTX* result in complete deletion of the HIT and Znf domains.[@B1] The mutation c.388C\>T (p.Gln130Ter) in affected members of family RDHM-02 introduced a stop codon into the *APTX* open reading frame ([Fig. 1D](#F1){ref-type="fig"}). This is probably a null allele due to invoking either nonsense-mediated decay of the mRNA[@B4] or degradation of the truncated protein. Western-blot analysis of lymphoblastoid cell lines derived from AOA1 patients homozygous for different nonsense mutations ([Fig. 1C](#F1){ref-type="fig"}) has revealed undetectable levels of aprataxin,[@B1] which supports the present hypothesis.

Frame-shift, splice-site, and nonsense mutations of *APTX* are believed to cause early onset and more-severe phenotypes compared to those caused by the missense mutations.[@B5] This is supported by the patients in family RDHM-02 having severe features of AOA1 with an early disease onset. Oculomotor apraxia and chorea have been observed in 85% and 80% of cases, respectively,[@B5] and the latter manifestations were present in some of the patients in family RDHM-02 ([Supplementary Table 1](#S1){ref-type="supplementary-material"} in the online-only Data Supplement). Polyneuropathy and a complete loss of ambulation have been reported in AOA1 patients at 7--10 years after the disease onset.[@B5] However, these phenotypes were clinically observed only in individual VI:11 in the present study, with the limitation that none of the affected individuals were evaluated by electrophysiological testing since this was not available. Hypercholesterolemia (75%) and hypoalbuminemia (83%) are variable features in AOA1 and appear at 10--15 years after disease onset.[@B5] The oldest present patient (individual VI:11) had elevated cholesterol but a normal albumin level ([Supplementary Table 1](#S1){ref-type="supplementary-material"} in the online-only Data Supplement). The phenotypic variability among the patients in family RDHM-02 carrying an identical mutation underlines the difficulty of establishing genotype-phenotype correlations in autosomal recessive AOA1.

The current research has identified a new variant of *APTX* and highlights the utility of whole-exome sequencing in diagnosing a rare Mendelian disorder that could only have been diagnosed at a highly specialized movement-disorder center based on clinical findings. These findings have major implications for the family and their counseling, which can now be facilitated by utilizing whole-exome sequencing data.
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###### Supplementary Table 1

Clinical features of family RDHM-02

![The RDHM-02 family and nonsense *APTX* variant segregated based on the phenotype. A: RDHM-02 pedigree. ^\*^Individuals for whom DNA was available. The arrows denote individuals for whom whole-exome sequencing was performed. The genotypes of *APTX* (c.388C\>T) are indicated below the corresponding symbols for individual subjects. B: Electropherogram of *APTX* sequence analyses. The site of the mutation is indicated by an arrow. C: Diagram of *APTX* (NM_175073.2), with black boxes denoting translated exons and plain boxes denoting 5′ and 3′ untranslated regions. Introns are depicted by horizontal lines. D: Aprataxin. The protein domains are shaded. All reported nonsense mutations are shown, and the p. Gln130Ter variant identified in family RDHM-02 is boxed. FHA: forkhead-associated domain at the N-terminal, HIT: histidine triad domain, Znf: zinc finger domain at the C-terminal.](jcn-13-303-g001){#F1}
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